Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 5, 2013, Pages 425-442

  Ohira, Hideo ^a,b   Fujioka, Yoshio ^a   Katagiri, Chikae ^a   Mamoto, Rie ^a   Aoyama Ishikawa, Michiko ^b   Amako, Katsumi ^a   Izumi, Yoshihiro ^c   Nishiumi, Shin ^c   Yoshida, Masaru ^c   Usami, Makoto ^b   Ikeda, Masamichi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipocyte; Butyrate; Free fatty acid; Lipolysis; Macrophage

Indexed keywords

BUTYRIC ACID; FATTY ACID; FATTY ACID BINDING PROTEIN 4; GLYCEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRATE; PALMITIC ACID; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; INFLAMMATION; LIPOLYSIS; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BUTYRATES; CELL LINE; CHEMOKINE CCL2; COCULTURE TECHNIQUES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPASE; LIPOLYSIS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; PARACRINE COMMUNICATION; PERTUSSIS TOXIN; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878414731     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.15065     Document Type: Article

References (43)

1. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet, 2005; 365: 1415-1428
2. Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, Sarwar N, Kizer JR, Lawlor DA, Nordestgaard BG, Ridker P, Salomaa V, Stevens J, Woodward M, Sattar N, Collins R, Thompson SG, Whitlock G, Danesh J: Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet, 2011; 377: 1085-1095
3. Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol, 2004; 25: 4-7
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 2003; 112: 1821-1830
5. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M: MCP-1 contributes to macrophage infiltration into adopose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest, 2006; 116: 1494-1505
6. Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol, 2005; 25: 2062-2068
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest, 2003; 112: 1796-1808
8. Suganami T, Ogawa Y: Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol, 2010; 88: 33-39
9. Hemmrich K, Thomas GP, Abberton KM, Thompson EW, Rophael JA, Penington AJ, Morrison WA: Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity, 2007; 15: 2951-2957
10. Topping DL, Clifton PM: Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev, 2001; 81: 1031-1064
11. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 1987; 28: 1221-1227
12. Andoh A, Tsujikawa T, Fujiyama Y: Role of Dietary Fiber and Short-Chain Fatty acids in the Colon. Current Pharmaceutical Design, 2003; 9: 347-358
13. Gibson P, Rosella O: Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut, 1995; 37: 536-543
14. Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson, IR: Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci U S A, 1997; 94: 10279-10284
15. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J: Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res, 2008; 28: 321-328
16. Park JS, Lee EJ, Lee JC, Kim WK, Kim HS: Anti-inflammatory effects of short chain fatty acids in IFN-gammastimulated RAW264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int Immunopharmacol, 2007; 7: 70-77
17. Miyoshi M, Sakaki H, Usami M, Iizuka N, Shuno K, Aoyama M, Usami Y: Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin Nutr, 2011; 30: 252-258
18. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ: The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem, 2003; 278: 11312-11319
19. Hong YH, Nishimura Y, Hishikawa D, Tsuzuki H, Miyahara H, Gotoh C, Choi KC, Feng DD, Chen C, Lee HG, Katoh K, Roh SG, Sasaki S: Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology, 2005; 146: 5092-5099
20. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest, 2006; 116: 3015-3025
21. Martins de Lima T, Gorjao R, Hatanaka E, Cury-Boaventura MF, Portioli Silva EP, Procopio J, Curi R: Mechanisms by which fatty acids regulate leucocyte function. Clin Sci (Lond), 2007; 113: 65-77
22. Meijer K, de Vos P, Priebe MG: Butyrate and other shortchain fatty acids as modulators of immunity: what relevance for health? Curr Opin Clin Nutr Metab Care, 2010; 13: 715-721
23. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J: Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes, 2009; 58: 1509-1517
24. Vinolo MA, Rodrigues HG, Festuccia WT, Crisma AR, Alves VS, Martins AR, Amaral CL, Fiamoncini J, Hirabara SM, Sato FT, Fock RA, Malheiros G, Dos Santos MF, Curi R: Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice. Am J Physiol Endocrinol Metab, 2012; 303: E272-E282
25. Granger DL, Taintor, RR, Boockvar KS, Hibbs JB: Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol, 1996; 268: 142-151
26. Duncombe WG: The colorimetric micro-determination of long-chain fatty acids. Biochem J, 1963; 88: 7-10
27. Chait A, Kim F: Saturated fatty acids and inflammation: who pays the toll?. Arterioscler Thromb Vasc Biol, 2010; 30: 692-693
28. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M: Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem, 2003; 278: 25481-25489
29. Cammisotto PG, Bukowiecki LJ: Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol, 2002; 283: C244-C250
30. Permana PA, Menge C, Reaven PD: Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun, 2006; 341: 507-514
31. Kurokawa J, Nagano H, Ohara O, Kubota N, Kadowaki T, Arai S, Miyazaki T: Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue. Proc Natl Acad Sci U S A, 2011; 108: 12072-12077
32. Granneman JG, Moore HP: Location, location: protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab, 2008; 19: 3-9
33. Cawthorn WP, Sethi JK: TNF-alpha and adipocyte biology. Febs Lett, 2008; 582: 117-131
34. Guan HP, Li Y, Jensen MV, Newgard CB, Steppan CM, Lazar MA: A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med, 2002; 8: 1122-1128
35. Furuhashi M, Ishimura S, Miura T: Lipid chaperones and metabolic inflammation. Int J Inflam, 2011; 642612. Epub 2011 Oct 30
36. Jenkins-Kruchten AE, Bennaars-Eiden A, Ross JR, Shen WJ, Kraemer FB, Bernlohr DA: Fatty acid-binding protein-hormone-sensitive lipase interaction. J Biol Chem, 2003; 278: 47636-47643
37. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, Yanagisawa M: Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A, 2004; 101: 1045-1050
38. Ohira H, Fujioka Y, Katagiri C, Yano M, Mamoto R, Aoyama M, Usami M, Ikeda M: Butyrate enhancement of inteleukin-1 beta production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells. J Clin Biochem Nutr, 2012; 50: 59-66
39. Wolever TM, Josse RG, Leiter LA, Chiasson JL: Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism, 1997; 46: 805-811
40. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, Fischer-Posovszky P, Barth TF, Dragun D, Skurk T, Hauner H, Bluher M, Unger T, Wolf AM, Knippschild U, Hombach V, Marx N: T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol, 2010; 28: 1304-1310
41. Bailon E, Cueto-Sola M, Utrilla P, Rodriguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, Galvez J, Comalada M: Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology, 2010; 215: 863-873
42. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ: Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab, 2008; 295: E1160-E1166
43. Kaneki M, Shimizu N, Yamada D, Chang K: Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal, 2007; 9: 319-329